Clinical Trials Logo

Filter by:
NCT ID: NCT05359302 Recruiting - Quality of Life Clinical Trials

Effects of Ramadan Fasting on Sleeping and Quality of Life

Start date: March 15, 2022
Phase:
Study type: Observational [Patient Registry]

Include participants who intend to practice Ramadan fasting and accept to complete the three part of the study .

NCT ID: NCT05352893 Completed - Clinical trials for Generalized Pustular Psoriasis

Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP

GEMINI1
Start date: April 14, 2022
Phase: Phase 3
Study type: Interventional

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of imsidolimab compared with placebo in adult subjects with generalized pustular psoriasis (GPP).

NCT ID: NCT05352490 Recruiting - Dyspnea Clinical Trials

Diagnosis of Heart Failure in Chronic Obstructive Pulmonary Disease Using the Lung Ultrasound

Start date: March 1, 2022
Phase:
Study type: Observational

Acute Heart failure (AHF) is a common cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This association is frequently underestimated with regard to the difficulty of clinical diagnosis. The investigators expect that the application of the lung ultrasound could be useful in this issue.

NCT ID: NCT05340972 Recruiting - Heart Diseases Clinical Trials

Evaluate the Predictive Impact of the MEESSI Score

MEESSI
Start date: January 15, 2009
Phase:
Study type: Observational

Our primary purpose is to assess MEESSI score in predicting mortality and readmission of patients managed for acute heart failure (AHF) in Emergency Department. European Society of Cardiology recommend risk stratification for patients with AHF.

NCT ID: NCT05331443 Enrolling by invitation - Clinical trials for Endothelial Dysfunction

Effects of Ramadan Fasting on Endothelial Function

Start date: March 15, 2022
Phase:
Study type: Observational [Patient Registry]

Include participants who intend to practice Ramadan fasting and accept to complete the three part of the study .

NCT ID: NCT05330650 Completed - Clinical trials for Cesarean Section; Infection

Evaluation of Triclosan Coated Suture in Obstetrical Surgery

Start date: November 1, 2020
Phase: Phase 4
Study type: Interventional

A prospective comparative randomized blinded study conducted in the obstetrics gynecology department of Ben Arous hospital over an eight-month period between November 2020 and June 2021. The aim of this study is to evaluate effectiveness of Triclosan coated suture use in obstetrical surgery.

NCT ID: NCT05327374 Completed - COPD Exacerbation Clinical Trials

Use of ΔIVC for Early Diagnosis of AHF in AECOPD

Start date: March 1, 2022
Phase:
Study type: Observational

Acute Heart failure (AHF) is a common cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This association is frequently underestimated with regard to the difficulty of clinical diagnosis. The investigators expect that the application of the inferior vena cava collapsibility index (ΔIVC)could be useful in this issue.

NCT ID: NCT05325606 Recruiting - Stroke Clinical Trials

Registry-based Stroke in Tunisia

RAV-TUN
Start date: June 1, 2020
Phase:
Study type: Observational [Patient Registry]

Study the prevalence of strokes in the emergency department (ED) and their possible eligibility for thrombolysis.

NCT ID: NCT05325580 Recruiting - Head Pain Clinical Trials

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

Start date: December 1, 2021
Phase: Phase 3
Study type: Interventional

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

NCT ID: NCT05314673 Completed - Pterygium Clinical Trials

Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients

Start date: January 1, 2019
Phase: Phase 4
Study type: Interventional

Purpose: To assess the efficacy and safety of a single preoperative intra-lesional bevacizumab injection in primary pterygium. Methods: The investigators conducted a randomized controlled interventional study from January 2019 to December 2020. The study included a total of 60 patients (60 eyes) with primary pterygium. The investigators defined two groups of 30 patients each. Group A received an intralesional injection of bevacizumab (Avastin), one month before surgery (lesion excision and conjunctival autograft). Group B (control) had only the surgical treatment. Patients were followed up seven days (D7), one month (M1), three months (M3), and six months (M6) post-operatively. Pre-, per- and post-operatively, photographs of the lesions were taken, as well as a pathological examination. The main outcome measures were the change in functional discomfort following intralesional bevacizumab injection and pterygium recurrence. Recurrence was defined by fibrovascular tissue growth extending more than 1 mm across the limbus. Therapeutic success was defined as the absence of pterygium recurrence in M6.